We are live on ! Find out more
AWGLSCP

ABG-WTT Global Life Science Capital Partners Portfolio holdings

AUM $12.3M
1-Year Est. Return 3.13%
This Fund
S&P 500
This Quarter Est. Return
+39.63%
1 Year Est. Return
-3.13%
3 Year Est. Return
+108.96%
5 Year Est. Return
-90.91%
10 Year Est. Return
–
AUM
$28.3M
AUM Growth
+$16M
Cap. Flow
+$19.6M
Cap. Flow %
68.97%
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
MDVL
MedAvail Holdings, Inc. Common Stock
MDVL
+$19.6M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDVL
1
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
$23M 81.12%
300,590
+222,871
+287% +$19.6M
RPID icon
2
Rapid Micro Biosystems
RPID
$86.2M
$4.46M 15.75%
1,038,296
– –
LUNG icon
3
Pulmonx
LUNG
$87.6M
$886K 3.13%
60,204
– –

Similar funds

M
MetLife New York $12.3M AUM 29% 1-Year Est. Return
MAMNY
Marathon Asset Management (New York) New York $12M AUM 8.79% 1-Year Est. Return
IWM
Immaculate Wealth Management Mesa, Arizona $12.7M AUM
VH
Vitol Holding Rotterdam, Netherlands $11.9M AUM 27.28% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
CCM
Crabel Capital Management Los Angeles, California $10.8M AUM 3.34% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return

ABG-WTT Global Life Science Capital Partners's Q2 2022 Portfolio in Review

As of Q2 2022, ABG-WTT Global Life Science Capital Partners held 3 positions worth $28.3M, up 130% from $12.3M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

ABG-WTT Global Life Science Capital Partners deployed $19.6M of net new capital in Q2 2022, adding to 1 existing holding.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • ABG-WTT Global Life Science Capital Partners added most to MedAvail Holdings, Inc. Common Stock in Q2 2022, an estimated $19.6M increase.
  • ABG-WTT Global Life Science Capital Partners's ten largest holdings make up 100% of its $28.3M portfolio in Q2 2022.
  • ABG-WTT Global Life Science Capital Partners opened 0 new positions and closed 0 in Q2 2022.
  • ABG-WTT Global Life Science Capital Partners's portfolio value rose 130% quarter-over-quarter to $28.3M.

Based on ABG-WTT Global Life Science Capital Partners's 13F filing for Q2 2022, filed 15 Aug 2022.